Literature DB >> 2564837

Rapid isolation of moderate and highly polymorphic DNA fragments mapping close to WT (Wilms' tumour) and AN2 (aniridia) on chromosome 11.

P A Boyd1, S Christie, N D Hastie, D J Porteous.   

Abstract

Genes implicated in the development of Wilms' tumour (WT) and aniridia (AN2) have been localised to a sub-region of band p13 on chromosome 11 by molecular and cytogenetic characterisation of WAGR syndrome patients carrying variable constitutional deletions. Polymorphic markers for the region would be valuable for linkage analysis in the familial forms of both Wilms' tumour and aniridia, as well as for studying somatic rearrangements of chromosome 11 in a variety of tumour types. Here we describe the isolation and characterisation of three frequently polymorphic arbitrary DNA fragments that map proximal to the AN2 and WT loci.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2564837     DOI: 10.1007/BF00283689

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  25 in total

1.  Hitch-hiking from HRAS1 to the WAGR locus with CMGT markers.

Authors:  W Bickmore; S Christie; V van Heyningen; N D Hastie; D J Porteous
Journal:  Nucleic Acids Res       Date:  1988-01-11       Impact factor: 16.971

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  Del 11p/aniridia complex. Report of three patients and review of 37 observations from the literature.

Authors:  C Turleau; J de Grouchy; M F Tournade; M F Gagnadoux; C Junien
Journal:  Clin Genet       Date:  1984-10       Impact factor: 4.438

4.  Lambda replacement vectors carrying polylinker sequences.

Authors:  A M Frischauf; H Lehrach; A Poustka; N Murray
Journal:  J Mol Biol       Date:  1983-11-15       Impact factor: 5.469

5.  Genetic mechanisms of tumor-specific loss of 11p DNA sequences in Wilms tumor.

Authors:  D D Dao; W T Schroeder; L Y Chao; H Kikuchi; L C Strong; V M Riccardi; S Pathak; W W Nichols; W H Lewis; G F Saunders
Journal:  Am J Hum Genet       Date:  1987-08       Impact factor: 11.025

6.  Molecular analysis of chromosome 11 deletions in aniridia-Wilms tumor syndrome.

Authors:  V van Heyningen; P A Boyd; A Seawright; J M Fletcher; J A Fantes; K E Buckton; G Spowart; D J Porteous; R E Hill; M S Newton
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

7.  Use of catalase polymorphisms in the study of sporadic aniridia.

Authors:  P Boyd; V van Heyningen; A Seawright; G Fekete; N Hastie
Journal:  Hum Genet       Date:  1986-06       Impact factor: 4.132

8.  The beta-subunit of follicle-stimulating hormone is deleted in patients with aniridia and Wilms' tumour, allowing a further definition of the WAGR locus.

Authors:  T Glaser; W H Lewis; G A Bruns; P C Watkins; C E Rogler; T B Shows; V E Powers; H F Willard; J M Goguen; K O Simola
Journal:  Nature       Date:  1986 Jun 26-Jul 2       Impact factor: 49.962

9.  Rapid and quantitative detection of unique sequence donor DNA in extracts of cultured mammalian cells: an aid to chromosome mapping.

Authors:  D J Porteous
Journal:  Somat Cell Mol Genet       Date:  1985-09

10.  Del11p13/nephroblastoma without aniridia.

Authors:  C Turleau; J de Grouchy; C Nihoul-Fékété; J L Dufier; F Chavin-Colin; C Junien
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.